SUMMARY The excretion of 2,3-dinor-6-keto prostaglandin Fla, a major urinary metabolite of prostacyclin, and the formation of thromboxane B2, a stable metabolite of thromboxane A2, by platelets stimulated by adenosine diphosphate, were studied in alcoholics, who had been admitted for detoxification. Once prolonged heavy drinking had stopped, platelet count and thromboxane formation, calculated either per 107 platelets or per litre of blood, significantly increased (p < 0 05), while the skin bleeding time and urinary excretion of the metabolite of prostacyclin decreased (p < 005). The balance between prostacyclin and thromboxane therefore seemed to favour the excretion of prostacyclin while it shifted to favour thromboxane formation about a week later.
The eicosanoids thromboxane A2 (TXA2)1 and prostacyclin (PGI2)2 3 represent the opposite poles of an intravascular homeostatic mechanism for platelet aggregation.
We found previously that the formation of platelet generated TXA2, measured from plasma as its hydrolysis product thromboxane B2 (TXB2), was enhanced shortly after ethanol withdrawal in alcoholics.i6
Little is known about the changes in the prostacyclin system during this period. 7 The aim of this study was to extend the observations on platelet reactivity and haemostasis in alcoholics during ethanol withdrawal and to include the prostacyclin system. By measuring platelet capacity to generate TXB2, as well as body synthesis of PGI2-reflected by urinary 2,3-dinor-6-keto prostaglandin Fta (2,3-dinor-6-keto PGF1,), the major PGI2 metabolite we hoped to obtain an indication of the balance between the proaggregatory TXA2 and antiaggregatory PGI2.
Material and methods
Eleven normotensive male alcoholics, aged 28 to 50 years (mean 41 years) were studied. All had been admitted to our inpatient detoxification programme. Informed consent was obtained from each.
Accepted for publication 2 December 1986 The men had abused alcohol for 11 to 24 years (mean 16 years). The last binge before admission to the clinic had lasted from 14 to 90 days (mean 42 days). The mean alcohol consumption (hard liquor) had averaged 4 3 (range 177-72) g/kg of body weight per day. The patients denied drinking additives and taking any drugs during the week preceding enrolment in the study and none had salicylates in their urine the day before blood and urine sampling.
All the alcoholics were smokers, consuming at least 20 The product of the platelet count in the whole blood and platelet TXB2 formation per 107 platelets provided an indication of the capacity of a unit (one litre) of circulating blood to produce TXB2 (figure). On the day after admission the capacity to form TXB2 per litre of blood was normal.5 One week later the capacity of platelets to form TXB2 was increased. More To test the possibility that older subjects might have different eicosanoid formation than younger ones the data were separately analysed with regard to age. No significant correlations were found between the age of the patients and the number of eicosanoids produced.
Discussion
The balance between the two principal metabolites of arachidonic acid, proaggregatory and vasoconstrictory TXA2, and antiaggregatory and vasodilatory PGI2 seems to be important for primary haemostasis in vivo.3 12 The measurement of the inactive metabolite TXB2 in plasma, after stimulation of platelets in PRP, is a reflection of platelet capacity to synthesise TXA2. 'o Furthermore, the stimulated TXB2 formation, calculated per litre of blood, should be a measure of the TXA2 synthesis potential in the circulating blood.
The concentrations of PGI2 or its metabolites in plasma are very low.'3 Urine is the major route of excretion of prostacyclin metabolites in man. The major metabolite is 2,3-dinor-6-keto PGF,. which, however, accounts for less than 10% of the PGI2 metabolised in the body. '4 Nevertheless, the excretion of PGI2-M in relation to urinary creatinine is a useful measure of individual changes in the total body synthesis of PGI2.l5
During the alcohol withdrawal period, we found a large increase in TXB2 production in platelets stimulated by adenosine diphosphate ex vivo. The effect was particularly obvious when expressed as TXB2 produced per litre of whole blood. These findings agreed with our earlier observations in alcoholics, showing that platelets stimulated by adenosine diphosphate develop enhanced capacity to form TXB2 one to two weeks after drinking has stopped.4 '6 The results of the present study suggest that changes may occur even in the endogenous synthesis of PGI2. The excretion of PGI2-M was raised one day after stopping drinking, but in contrast to the Neiman, Hillbom, Benthin, Anggard production of platelet TXB2, it decreased with abstinence.
It is possible to speculate why these changes in the thromboxane-prostacyclin system occur during alcohol withdrawal. It is well known that the platelet count is depressed after a period of prolonged drinking, and this has been attributed to the toxic effects of ethanol on platelets and bone marrow."6 Moreover, changes in dietary habits, together with intestinal malabsorption and disturbances in the utilisation of nutrients,17 may contribute to the impaired activity of megakaryocytes.
The diminished capacity of platelets to form TXB2 could also be a consequence of the decreased availability or synthesis of arachidonic acid that has been described in experimental animals and humans. '8 Furthermore, the ethanol-induced production of lipid peroxides'9 and possible stimulation of cyclooxygenase by these compounds,20 as well as the availability of the inhibitors of lipid peroxidation, might have influenced the ability of platelets to produce thromboxane after a period of heavy drinking. According to our observations, lipid peroxides, measured as malondialdehyde, might be increased in plasma (unpublished observations), whereas the concentrations of vitamin E, an important free radical scavenger and inhibitor of lipid peroxidation in the membrane,21 were found to be normal in alcoholics after heavy drinking had stopped.22
After stopping drinking an increased platelet count often occurs.23 A consistent finding in the previous studies"6 was that the new platelets were hyperreactive to adenosine diphosphate stimulation aind form more TXB2 than the normal population of platelets, a finding which was also confirmed by the results of this study.
The extent of the effect of ethanol ingestion on PGI2 synthesis is still unknown. According to our own study ingestion of 0-25 g/kg body weight of ethanol did not change the urinary excretion of PGI2-M, suggesting that the synthesis of prostacyclin under these conditions was not affected.1'
Other investigators, however, found an increase of some prostacyclin metabolites in plasma by radioimmunoassay shortly after ingestion of 32 g of ethanol.24 Higher doses of ethanol might have completely different effects, as at least in vitro ethanol seems to stimulate the formation of PGI225 in a concentration dependent way.
The raised concentrations of urinary PGI2-M seen after a period of prolonged heavy drinking could also result from enhanced adrenergic tone26 associated with ethanol withdrawal. Our patients clearly showed increased heart rate and blood pressure (data not shown) at the beginning of detoxification.
Whatever the reason, we have firm evidence to sup-port an increase in the formation of antiaggregatory PGI2 with concomitant diminished overall capacity of platelets to form TXB2. The prostacyclinthromboxane balance thus favours PG2 which is consistent with the increased bleeding time.
After one week of withdrawal there was an increase in the capacity of platelets to form TXB2, while the body formation of PGI2, as observed by urinary PGI2-M, decreased. The prostacyclin-thromboxane balance was then shifted to thromboxane, and a decrease in bleeding time occurred. The changes in the balance of these eicosanoids observed in this study could therefore be associated with the regulation of platelet activity. There is epidemiological evidence from different parts of the world to suggest that alcoholism is a risk factor for several types of thromboembolic and haemorrhagic disease.27 -29 As the prostacyclinthromboxane balance might be important in maintaining the integrity and patency of the vascular space the disturbances in this balance during ethanol withdrawal period could be one of the predisposing mechanisms for thromboembolic vascular disease and haemorrhagic complications.
In conclusion, the results of our study indicate that in alcoholics the balance between prostacyclin and thromboxane favours prostacyclin immediately after heavy drinking is stopped but that shortly thereafter the balance favours thromboxane. These changes are of importance for primary haemostasis and could contribute to the aetiology of vascular complications seen in alcoholics.
